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Abstract. Inflammation and desmoplasia are frequently 
identified in the tumor microenvironment, and have been 
demonstrated to be effective modulators of malignant biological 
events. However, the mechanisms by which the inflammatory 
microenvironment and interstitial fibrosis interact with one 
another remain to be elucidated. The present study aimed to 
investigate the degree of inflammation and interstitial fibrosis 
in tongue squamous cell carcinoma (TSCC), and how this acts 
to affect the outcome of TSCC. Tissue samples from 93 cases 
of TSCC and paired tumor-adjacent non-neoplastic tongue 
epithelium, as well as 14 cases of epithelial dysplasia, were 
used. Interstitial collagen fibers were assessed using Masson's 
trichrome stain. Immunohistochemical identification of 
cancer‑associated fibroblasts (CAFs) and stroma‑infiltrating 
B cells was performed via detection of α-smooth muscle actin 
(SMA), vimentin, desmin and cluster of differentiation 19 
(CD19). The clinicopathological significance and overall 
survival of the TSCC patients were statistically analyzed. 
Regularly distributed CAFs and CD19+ B cells were identi-
fied in the TSCC stroma, whereas no CAFs or CD19+ B cells 
were observed in epithelial dysplasia samples or paired 
tumor-adjacent non-neoplastic tongue epithelium samples. The 
distribution of interstitial collagen fibers and CAFs was closely 
associated with the tumor stage of the primary cancer, and 
high levels of CD19+ B cells together with low CAF infiltration 
were identified to be associated with favorable prognosis in 
TSCC. In conclusion, the inflammatory and interstitial fibrotic 
microenvironments coexist in TSCC, and each has specific 
effects on disease outcome, individually or perhaps collec-
tively. However, it remains to be determined exactly how the 
microenvironments affect one another in TSCC.
Introduction
As we learn more about cancer, it has become clear that, as 
well as cancer cells, tumors exhibit an additional dimension of 
complexity, known as the ‘tumor microenvironment’. Typically, 
this consists of an extracellular matrix (ECM) scaffold that is 
populated by ostensibly normal cells, including fibroblast‑like 
cells, endothelial cells and immune cells (1). The tumor 
microenvironment is morphologically defined by desmoplasia, 
angiogenesis, inflammation and immune response. Each of 
these has an integral role in the carcinogenic process (1). It 
is believed that >90% of all cancers are caused by acquired 
somatic mutations and environmental factors, and germline 
mutation is the cause of carcinogenesis in ~10% of cases (2).
A role for inflammation in carcinogenesis is now widely 
accepted (3). Lymphocytes are a significant component of 
mononuclear cell populations that infiltrate human malignant 
tumors. The majority of previous studies have focused on 
cytotoxic T cells, as these demonstrate the greatest antitumor 
potential. However, analyses of tumor‑infiltrating B cells have 
identified the presence of these cells to be the next most impor-
tant predictor of disease outcome (4-6).
Unresolved inflammation commonly results in chronic 
inflammatory diseases, including fibrosis, pancreatitis and 
inflammatory bowel syndrome, which are known to greatly 
increase the risk of cancer (3). A systemic sclerosis study 
revealed that B cells may have a significant role in fibrosis, 
based on the observation that ex vivo co-culture of blood 
B cells and fibroblasts induced secretion of transforming 
growth factor β 1, interleukin (IL)-6, chemokine (C-C motif) 
ligand (CCL) 2 and collagen, as well as expression of α-smooth 
muscle actin (SMA) and matrix metalloproteinase 9 in dermal 
fibroblasts (7). However, to the best of our knowledge, it remains 
unclear whether there is a similar role for B cells in cancer.
One particular cell type, carcinoma-associated fibro-
blasts (CAFs; alternatively known as activated fibroblasts, 
myofibroblasts or tumor-associated fibroblasts), has been 
prominently investigated, and have been identified to be the 
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most abundant cells in the tumor microenvironment. They are 
typically recognized by their expression of α‑SMA, which 
is absent in normal dermal fibroblasts (8,9). In solid tumors, 
including breast cancer, CAFs may account for up to 90% of 
the tumor mass and have been observed to correlate with a 
desmoplastic phenotype (10). Notably, within a tumor micro-
environment infiltrated by immune cells, CAFs contribute 
to the maintenance of an inflammatory phenotype rather 
than being a passive bystander (11,12). We speculated that, if 
tumor‑infiltrating B cells functioned in interstitial fibrosis in 
malignancy, interaction with CAFs may be a potential mecha-
nism through which this may occur.
The significance of the tumor microenvironment in 
TSCC is currently a topic of significant interest. CAFs and 
tumor‑infiltrating B cells may affect the outcome of TSCC. 
to the best of our knowledge, the present study is the first 
to investigate the distribution and significance of interstitial 
fibrosis and stroma‑infiltrating B cells in TSCC.
Materials and methods
Patients and tissue samples. The present study was conducted 
at the Department of Oral and Maxillofacial Surgery of 
the Hospital of Stomatology, Guangdong Provincial Key 
Laboratory of Stomatology, Sun Yat-sen University (Guang-
zhou, China). Prior written informed patient consent and 
approval from the Institutional Research Ethics Committee 
was obtained. The investigations were performed using 
paraffin‑embedded TSCC samples and paired tumor‑adjacent 
non-neoplastic tongue epithelium samples from 93 patients. 
In addition, 14 samples were obtained from 14 patients with 
epithelial dysplasia tongue mucosa
Image analysis of interstitial collagen fibers. Pathological 
evaluation of every case was performed following hematoxylin 
and eosin staining. Tumor‑node‑metastasis (TNM) staging was 
determined according to the 2002 International Union Against 
Cancer TNM classification of malignant tumors (13). Cancer 
cell differentiation was classified into one of three grades (well, 
moderate and poor) using the 2006 World Health Organization 
classification (14). Collagen fiber bundles were stained and 
distinguished from cell components using Masson's trichrome 
stain.
Quantification of interstitial collagen fibers was performed 
by digital image analysis using Adobe Photoshop version 7.0 
(Adobe Systems, Inc., San Jose, CA, USA) and Image‑Pro Plus 
version 6.0 (Media Cybernetics, Inc., Rockville, MD, USA). 
A total of five random areas stained with Masson's trichrome 
stain in each specimen (magnification, x200) were acquired 
(Fig. 1A), and the red epithelial components were excluded 
from the analysis area (Fig. 1B). Subsequently, the total area 
was cut from Fig. 1B, with the exception of the blue collagen 
fibers (Fig. 1C). The percentage collagen fiber content (%CFC) 
in the tumor stroma was calculated using these last two images 
as follows: %CFC = (area of Fig. 1C/area of Fig. 1B) x 100. 
The mean %CFC of the five randomized selected areas was 
regarded as the CFC of the specimen.
Immunohistochemistry. Immunostaining was performed 
according to the manufacturer's protocols, using the following 
primary antibodies: Mouse monoclonal anti-human α‑SMA 
(catalog no., M0851; clone, 1A4; Dako, Glostrup, Denmark), 
rabbit monoclonal anti‑human vimentin (catalog no., 5741; 
clone, D21H3; Cell Signaling Technology, Inc., Danvers, MA, 
USA), mouse monoclonal anti‑human desmin (catalog no., 
M0760; clone, D33; Dako) and mouse monoclonal anti‑human 
CD19 (catalog no., ab31947; clone, 2E2B6B10; Abcam, 
Cambridge, MA, USA) antibodies.
Briefly, the paraffin-embedded specimens were cut 
into 4‑µm sections and heated at 60˚C for 2 h, followed by 
dewaxing and rehydration. For heat‑induced antigen retrieval 
(performed in a microwave oven at 240 W for 20 min), α‑SMA 
and desmin were treated with 10 mM Tris‑1 ethylenediamine-
tetraacetic acid buffer (pH 9), and vimentin and CD19 were 
treated with 10 mM citrate buffer (pH 6). The sections were 
subsequently treated with 3% hydrogen peroxide, followed 
by 5% bovine serum albumin. All slides were incubated with 
anti-α‑SMA (dilution, 1:100) and anti‑desmin (dilution, 1:150) 
for 1 h at room temperature, and with anti-vimentin (dilution, 
1:100) and anti‑CD19 (dilution, 1:350) overnight at 4˚C. Immu-
noreactivity was detected using labeled polymer-horseradish 
peroxidase reagent conjugated to AffiniPure goat anti-mouse 
(catalog no., E035111‑01) or AffiniPure goat anti‑rabbit 
(catalog no., E030120-02) immunoglobulin (Ig)G secondary 
antibody (EarthOx Life Sciences, Millbrae, CA, USA) and 
visualized with diaminobenzidine. Negative control experi-
ments were performed by replacing the primary antibody with 
phosphate-buffered saline.
Immunostaining of CAFs was assessed by evaluation 
of the staining intensity and percentage of α‑SMA. The 
percentage of immunopositive CAFs in non‑inflammatory and 
non-endothelial stromal cells was recorded as follows: 0, no 
positive cells; 1, 1‑33% positive cells; 2, 34‑66% positive cells; 
and 3, 67-100% positive cells. Staining intensity was consid-
ered to be 0 when there was no staining, 1 where positivity 
was observed only at magnification, x400, 2 in cases where 
staining was evident at x200 but not at x100 and 3 in fields 
where immunopositive cells were observed even at magnifica-
tion, x100. Multiplication of the percentage and intensity scores 
composed the staining index of each specimen. This index was 
classified as negative (score 0), low (score 1‑2), moderate (score 
3-4) or high (score 6-9) (15,16).
The lesion cores were initially scored by assessing the 
proportion of each core that comprised epithelia and stroma 
at low magnification, and subsequently scoring the number of 
positively stained CD19+ B cells within the core area (by direct 
counting up to 20, or by estimation to the nearest 10 when 
>20) at magnification, x200. Cores were scored as 0 (no cells 
present), 1 (1-5 cells), 2 (6-19 cells) or 3 (≥20 cells).
Statistical analysis. Fisher's least significant difference 
test and one factor analysis of variance were utilized for 
semi-quantitative image analysis of the collagen fibers in 
tissue samples. The association between the immune expres-
sion of each protein and clinical stage of disease, tumor (T)
stage, lymph node metastasis, degree of cell differentiation 
and prognosis were evaluated using the Kruskal-Wallis test 
or Mann‑Whitney U test. Multivariate survival analysis was 
performed with the Cox proportional hazards regression 
model. Survival curves were generated by the Kaplan‑Meier 
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method and compared using the log-rank test. P<0.05 was 
considered to indicate a statistically significant difference.
Results
Summary of patients. A total of 107 samples (93 TSCC and 
14 epithelial dysplasia) from patients aged 20-80 years (mean 
age, 52 years) were evaluated in the present study. The median 
follow-up time of the TSCC patients was 41 months. The 
clinical profiles of the TSCC patients included in the present 
study are summarized in Table I.
Image analysis of interstitial collagen fibers indicates an 
association between CFC and certain clinicopathological 
Table I. Clinicopathological features of tongue squamous cell carcinoma patients and their association with α‑SMA and CD19 
expression in the tumor microenvironment.
 Patients Collagen fiber content α‑SMA CD19
 ----------------------- --------------------------------------------- -------------------------------------------- --------------------------------------------
Characteristics n % Mean ± SD P‑value Mean rank P‑value Mean rank P‑value
Age, years    0.334  0.813  0.609
  <50 42 45.2 0.10±0.09  47.70  44.51 
  ≥50 51 54.8 0.12±0.10  46.42  47.22 
Gender    0.215  0.047  0.687
  Male 56 60.2 0.13±0.11  51.35  45.12 
  Female 37 39.8 0.10±0.09  40.42  47.28 
Clinical stage    0.239  0.374  0.912
  Ⅰ‑Ⅱ 51 54.8 0.10±0.09  43.44  44.25 
  Ⅲ‑Ⅳ 42 45.2 0.13±0.10  48.19  44.83 
Tumor stage    0.031  0.001  0.479
  1‑2 78 85.7 0.10±0.10  42.34  44.27 
  3‑4 13 14.3 0.17±0.09  67.69  49.69 
Node stage    0.966  0.209  0.207
  0 63 69.2 0.11±0.11  48.23  47.22 
  1‑3 28 30.8 0.11±0.10  40.98  40.16 
Pathological differentiation    0.231  0.125  0.217
  Well‑differentiated 47 50.5 0.10±0.09  39.80  44.64 
  Moderately differentiated 40 43.0 0.14±0.11  52.84  46.56 
  Poorly differentiated   6   6.5 0.10±0.10  44.00  26.50 
Overall survival    0.865  0.361  0.011
  Alive 39 41.9 0.12±0.11  30.86  35.95 
  Succumbed to disease 25 26.9 0.11±0.09  35.06  24.46 
  Missing 29 31.2 0.11±0.11     
Collagen fiber content is expressed as a ratio of the percentage of collagen fiber content in the tumor stroma. SMA, smooth muscle actin; CD, 
cluster of differentiation; SD, standard deviation; Mean rank, the mean as determined by the rank sum test.
 
Figure 1. Semi‑quantification image analysis of stromal collagen fibers. (A) Original Masson's trichrome stained image of the tissue section. Distinction of 
the cell compartment (red) and collagen fiber (blue) is clear. (B) Area of the stroma from image A demonstrating removal of the epithelial cell compartments. 
(C) Area of the interstitial collagen fiber compartment; all other areas removed, with the exception of the fibrous area from image B. Magnification, x200.
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features. The blue stained areas in the tissue sections following 
Masson's trichrome staining represented interstitial collagen 
fibers. No positive staining was detected in the paired 
tumor‑adjacent non‑neoplastic samples (Fig. 2A); however, in 
the epithelial dysplasia samples, a large number of interstitial 
collagen fibers were observed (Fig. 2B). A broad array of 
collagen fiber architectures were identified in TSCC samples, 
with certain samples exhibiting well-organized bundles 
surrounding epithelial clusters in the tissue section (Fig. 2C), 
and others in which interstitial collagen fibers were observed 
to intercalate between individual epithelial cells and interact 
with regions displaying poor tumor margins (Fig. 2D).
Analysis of CFC vs. clinicopathological criteria indicated 
a significant association between the T stage of TSCC and 
CFC (P=0.031; Fig. 3). The degree of CFC did not affect the 
overall survival rate of patients included in the present study 
(Table I).
Distribution patterns of CAFs vary with tissue sample type. 
Stromal spindle cells positive for α‑SMA and vimentin, 
Figure 2. Distribution patterns of interstitial collagen fibers in the tissue samples. (A) No positive staining of interstitial collagen fibers was observed in the 
paired tumor‑adjacent non‑neoplastic tongue epithelium samples. (B) In the epithelial dysplasia samples, profuse interstitial collagen fibers were identified. 
(C) Dense and well‑organized, parallel bundles of collagen fibers surrounding the tumor nest. (D) Complex fibers existed in large quantities around the cancer 
cells that were in the stroma. Magnification, x200.
Figure 3. Association between average %CFC and the T stage of tongue squamous cell carcinoma. Tumor interstitial CFC indicated a trend for increasing as 
the tumor increased in size, with the exception of T1 stage cases. The data is presented as the mean ± standard deviation. CFC, collagen fiber content; T, tumor.
  A   B
  C   D
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but negative for desmin, were regarded as CAFs (Fig. 4). 
One consistent feature of CAFs in desmoplastic lesions is a 
myofibroblast phenotype, which is based on the synthesis 
of intracellular smooth muscle-like proteins, in particular 
α‑SMA (17). Therefore, the present study assessed CAFs by 
evaluating the staining intensity and percentage of α‑SMA.
For immunostaining of α‑SMA, blood vessels present 
within the connective tissue of the immunostained sections 
served as a positive internal control and stained with an inten-
sity of 3 in all cases.
Despite the distribution of profuse interstitial collagen 
fibers, no positive staining of α‑SMA was detected in the 
epithelial dysplasia samples or the paired tumor-adjacent 
non-neoplastic samples, with the exception of blood vessels 
(Fig. 4D and E). Thus, CAFs were not considered to be 
present in these tissue sample types. In TSCC samples, in 
non‑inflammatory and non‑endothelial stromal cells immedi-
ately adjacent to carcinomatous islands, the α‑SMA staining 
index was negative in 17.2%, low in 32.3%, moderate in 28.0% 
and high in 22.6% of all cases investigated. The distribution 
of CAFs and interstitial collagen fibers was identified to be 
highly homogeneous between %CFC and α‑SMA staining 
index (P<0.001; Table II), and a trend for increasing amounts 
of α‑SMA‑positive CAFs was clearly demonstrated with 
regard to the increasing T stage of TSCC patients (P=0.001), 
which was consistent with results achieved with Masson's 
trichrome staining.
Additional investigation of CAF distribution in different 
samples revealed a highly heterogeneous pattern, even within 
a single tumor, and ‘spindle’ and ‘network’ patterns were 
observed. In the ‘network’ pattern, CAFs were particularly 
abundant and occupied almost the entire tumor stroma 
(Fig. 4F). The ‘spindle’ pattern was characterized by stromal 
CAFs that were located at the periphery of carcinomas in 
1‑3 concentric layers; this pattern was additionally observed 
to be adjacent to a number of tumor islands/nests (Fig. 4G). 
However, no significant difference between the two distribu-
tion patterns with regard to the survival benefit of the disease 
was identified in the present study (P=0.560).
Distribution patterns of CD19+ stroma‑infiltrating B cells 
vary with tissue sample type. CD19+ stroma‑infiltrating B cells 
were identified only in TSCC samples, even in tumors exhib-
iting low densities of the cellular components of the ECM. 
CD19+ stroma‑infiltrating B cells were primarily enriched in 
the invasive margin; however, only small fractions of B cells 
sporadically infiltrated into the peritumoral areas. The majority 
of CD19+ stroma‑infiltrating B cells resided in follicular aggre-
gates, resembling the previously reported ‘Crohn's‑like reaction’ 
model of tumor‑infiltrating lymphocytes (TILs; Fig. 5) (18).
Figure 4. Immunohistochemical staining of CAFs. CAFs were (A) α‑SMA and (B) vimentin positive, but (C) desmin negative. (D and E) Negative staining 
of α‑SMA in the epithelial dysplasia and paired tumor‑adjacent non‑neoplastic tongue epithelium samples. (F) Typical ‘networkʼ pattern formed when CAFs 
are particularly abundant and occupy almost the entire tumor stroma. (G) ‘Spindleʼ pattern, in which CAFs are arranged in 1‑3 rows in a regular order in the 
periphery of the neoplastic islands. CAFs, cancer‑associated fibroblasts; SMA, smooth muscle actin.
Table II. Immunohistochemical staining index for α‑SMA and CD19 in ED, TSCC and PTANNE.
 α‑SMA, n CD19, n
Tissue ----------------------------------------------------------------------------- -------------------------------------------
type Negative Low Moderate High P‑value R‑value 0 1 2 3 P‑value R‑value
ED 14   0   0   0   14   0   0   0 
PTANNE 93   0   0   0 <0.001 ‑0.720 93   0   0   0 <0.001 ‑0.872
TSCC 16 30 26 21     7 29 34 23
P‑values were calculated using Spearman's rank correlation analysis. SMA, smooth muscle actin; CD, cluster of differentiation; ED, epithelial 
dysplasia; PTANNE, paired tumor‑adjacent non‑neoplastic epithelium; TSCC, tongue squamous cell carcinoma.
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Statistical analysis of CD19+ stroma-infiltrating 
B cell density revealed a significant difference between 
TSCC samples and epithelial dysplasia samples or paired 
tumor-adjacent non‑neoplastic samples. A positive correlation 
between the density of CD19+ stroma‑infiltrating B cells and 
overall survival of TSCC patients was identified (P=0.008; 
Fig. 6).
Chronic inflammatory fibrotic microenvironments of TSCC 
may be associated with patient survival. CAFs and CD19+ 
stroma‑infiltrating B cells were observed to coexist in the TSCC 
stroma, however, they did not in the paired tumor-adjacent 
non-neoplastic samples nor the epithelial dysplasia samples. 
In a number of cases, there was a tumor capsule-like structure 
formed by fibrous connective tissue surrounding the neoplastic 
mass, and an uneven distribution of CD19+ stroma‑infiltrating 
B cells was observed. In certain cases, CD19+ stroma‑infil-
trating B cells only assembled outside the tumor capsule, 
whereas in other cases they were identified on both sides. In 
these cases, CD19+ stroma‑infiltrating B cells appeared to have 
penetrated the tumor capsule and were able to interact directly 
with tumor cells. Statistical analysis revealed that TSCC cases 
exhibiting severe desmoplasia and low inflammatory status 
possessed the lowest overall survival rate, and cases demon-
strating low desmoplasia and a high inflammatory degree had 
significantly improved overall survival rates in comparison 
(P=0.040).
Discussion
To the best of our knowledge, the present study is the first 
to investigate the distribution of interstitial fibrosis and 
stroma‑infiltrating B cells in the stroma of epithelial dysplasia, 
TSCC and paired tumor-adjacent non-neoplastic samples, 
and to analyze their clinical significance. The coexistence 
of two significant features in the TSCC microenvironment 
was investigated, and it was identified that CAFs and CD19+ 
stroma-infiltrating B cells were associated with the clini-
copathological characteristics and overall survival of TSCC 
patients.
In the present study, massively disseminated CAFs 
were observed in the TSCC stroma, whereas no CAFs were 
detected in the epithelial dysplasia and paired tumor-adjacent 
non‑neoplastic epithelium samples. The presence of CAFs was 
Figure 6. Kaplan‑Meier survival curves for tongue squamous cell carcinoma patients according to (A) α‑SMA and (B) CD19 staining in the tumor stroma. 
The log-rank test revealed that the survival rate between various scores of α‑SMA staining was not statistically significant (P=0.504), however, a statisti-
cally significant difference was observed between various scores of CD19 expression (P=0.008). SMA, smooth muscle actin; CD, cluster of differentiation.
Figure 5. Follicular aggregates of stroma‑infiltrating B cells in the stroma of tongue squamous cell carcinoma, exhibiting the ‘Crohn's‑like reaction’.
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observed to be positively correlated with the T stage of these 
patients, indicating a tumor‑promoting function of CAFs. 
This result was consistent with the results of previous studies, 
which had observed that CAFs had a tumor‑promoting role 
and protumorigenic properties (19,20). Fibrotic histological 
alterations of the stroma may range from a predominantly 
cellular stroma with little ECM, to a dense tissue with a 
minimum of cells and a maximum content of matrix (21). In 
breast cancer, high fibrillar collagen density correlates with 
increased mammographic density in women, which augments 
breast cancer risk four-fold (22).
Highly heterogeneous arrangements of CAFs and collagen 
fibers were observed to be present in the stroma of TSCCs. 
Even with identical degrees of CAFs/interstitial fibrosis, the 
organization of these components may vary significantly. 
Well-formed ‘spindle’ or ‘network’ patterns were observed, 
as well as disorganised and chaotic patterns. However, statis-
tical analysis revealed no significant difference between the 
various patterns with regard to the 3-year survival rate of 
TSCC patients. Agarwal et al (23) identified that, as well as 
the arrangement, the type of collagen fiber was important. In 
an immunohistochemical study involving 35 tissue blocks, a 
direct association between the presence of type Ⅳ collagen 
and the differentiation degree of SCC cells was confirmed (23). 
Additional investigation concerning various distribution 
patterns of CAFs or specific types of interstitial collagen fibers 
in the TSCC microenvironment is required.
An additional notable finding of the present study was the 
identification of a positive correlation between the density of 
CD19+ stroma‑infiltrating B cells and overall survival. Density 
of CD19+ stroma‑infiltrating B cells was an independent prog-
nostic factor among all clinicopathological features studied. 
The impact of stroma‑infiltrating B cells in carcinogenesis has 
begun to be investigated. In particular, two specific subtypes 
of stroma‑infiltrating B cells, tumor‑evoked regulatory B cells 
(tBregs) and CD20+ TIL-B cells have attracted interest. There is 
no unique marker, or set of markers, that exclusively identifies 
tBregs, and they are defined as CD19+ B cells that are CD25High, 
B7-H11High, CD81High, CD86High, CCL6High, CD62LLow and 
IgMInt/Low (24). It has been proposed that tBregs demonstrate 
tumor-promoting action during squamous carcinogenesis (25). 
However, the present study revealed that CD19+ B cells were a 
favorable prognostic factor, which is similar to CD20+ B cells. 
Previous studies demonstrated that CD20+ B cells possessed 
a tumor suppressing function in breast and ovarian cancer, as 
well as hepatocellular carcinoma (5,6,26,27). The discrepancy 
may be explained by the hypothesis that CD19+ B cells have 
varying roles between different tumor cell types or tumor 
stages. This additionally indicates that the exact function 
of stroma‑infiltrating B cells in carcinogenesis and cancer 
progression is more complicated than expected, and additional 
studies are required to reveal the underlying mechanism.
The results of the present study demonstrated highly hetero-
geneous distribution patterns of interstitial collagen fibers 
and stroma‑infiltrating B cells in TSCC, and the appearance 
of the two was not necessarily isochronous. The distribu-
tion pattern of a large amount of interstitial fibrosis and low 
levels of CD19+ B cell infiltration resulted in reduced overall 
survival. This notable finding may indicate the occurrence 
of cross‑talk between CAFs and CD19+ B cells. It is believed 
that CAFs are initially educated by immune cells, due to the 
release of IL-1β, during the early stages of tumorigenesis, and 
as tumor progression occurs, they acquire the ability to recruit 
and regulate immune cells to an eventual immune-suppressed 
phenotype that is compatible with disease progression (28,29).
There are certain limitations in the present study, and the 
association between inflammation and interstitial fibrosis 
in the tumor microenvironment is complicated. The present 
study provided only preliminary results that indicated a coex-
istence of inflammation and interstitial fibrosis in the TSCC 
microenvironment. Additional studies are required to investi-
gate the presence of CD19+ B cells, as well as the presence of 
CD20+ B cells, tBregs and other cells in TSCC. Furthermore, 
additional studies are required in vivo to elucidate the dynamic 
interactions and exact roles of these cells in TSCC.
In conclusion, the present study revealed that the degree 
of CAFs/interstitial collagen fibers correlates with the T stage 
of TSCC, and the existence of CD19+ stroma-infiltrating 
B cells may serve a functional role in the TSCC inflammatory 
microenvironment. Distribution patterns of interstitial fibrosis 
and CD19+ B cells are associated with overall survival of TSCC 
patients. A pattern of high interstitial fibrosis and low levels 
of CD19+ B cells correlated with the lowest overall survival 
rate. The results of the present study may assist with additional 
investigation of inflammation and interstitial fibrosis in the 
TSCC microenvironment.
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